Bioorganic and medicinal chemistry letters p. 141 - 144 (1999)
Update date:2022-08-03
Topics:
Chu, Guo-Hua
Peters, Amy
Selcer, Kyle W.
Li, Pui-Kai
We report the development of (E)- and (Z)-4-hydroxytamoxifen sulfamates as estrone sulfatase inhibitors, potential therapeutic agents for the treatment of breast cancer. Both compounds competitively inhibit estrone sulfatase isolated from rat liver with apparent Ki of 35.9 μM for (E)-4-hydroxytamoxifen sulfamate and an apparent Ki of >500 μM for the (Z) isomer.
View MoreXi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Ningxia Soochow Agrochemical Limited Company
Contact:(+86）0512 6320 8190
Address:wujiang
Nanjing Yuance Industry&Trade Co., Ltd.
website:http://www.njyuance.cn/
Contact:+86-25-85439097
Address:B1702, Aoti Bldg, No. 130, Aoti Avenue, Nanjing, China
Changsha Yihai Chemical Technology Co.,ltd
Contact:0731- 85620465
Address:Room 23005, unit 2, the northern building of Xiangsong international building , NO.259 Shaoshan Road , Changsha , Hunan, China.(mainland)
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011，13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
Doi:10.1021/jo9613601
(1997)Doi:10.1021/ja01207a035
(1946)Doi:10.1016/S0040-4039(96)02075-8
(1996)Doi:10.1016/S0960-894X(99)00187-0
(1999)Doi:10.1016/S0968-0896(02)00612-0
(2003)Doi:10.1021/ja963295i
(1997)
